Clinical trial
Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy…
NCT00480701 · Institute for Neurodegenerative Disorders, Other · Completed
Key facts
| NCT number | NCT00480701 |
|---|---|
| Title | Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer Disease |
| Official title | Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT as a Marker of Acetylcholine Transporter Density in the Brain of Healthy Subjects and Patients With Alzheimer Disease |
| Acronym | IBVM001 |
| Lead sponsor | Institute for Neurodegenerative Disorders, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alzheimer Disease, Parkinson Disease |
| Intervention type | Drug |
| Interventions | [123I]-IBVM |
| Enrollment | 26 |
| Start date | Feb 1, 2007 |
| Primary completion | Oct 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | May 31, 2007 |
| Last update posted | May 7, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: